Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
Details for Australian Patent Application No. 2004240629 (hide)
International Classifications
Event Publications
8 December 2005 PCT application entered the National Phase
PCT publication WO2004/103364 Priority application(s): WO2004/103364
25 February 2010 Application Accepted
Published as AU-B-2004240629
15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
4 August 2011 Corrigenda
Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2004 Delete all reference to Application No. 2004240629.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004240630-Stable analogs of peptide and polypeptide therapeutics
2004240628-Hydrogel composition demonstrating phase separation
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser